Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.85
-0.15 (-5.00%)
At close: Aug 15, 2025, 3:59 PM
2.88
1.18%
After-hours: Aug 15, 2025, 06:58 PM EDT

Ventyx Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-119.03M -123.99M -135.12M -152.52M -171.3M -192.6M -192.96M -181.42M -157.86M -124.63M -108.43M -90.98M -73.29M -68.83M -83.75M -82.68M -77.06M -63.66M
Depreciation & Amortization
1.3M 1.3M 1.35M 1.44M 1.39M 1.22M 941K 688K 550K 514K 470K 336K 218K 119K 30K 14K 5K 1K
Stock-Based Compensation
20.22M 21.42M 22.93M 23.91M 26.47M 28.56M 28.59M 27.27M 23.43M 19.69M 16.57M 13.13M 9.94M 6.09M 2.73M 1.35M 396K 116.5K
Other Working Capital
5.1M 3.6M -7.92M -15.47M -8.39M -9.71M 3.16M 1.81M -12.35M -14.93M -6.77M 1.63M 6.64M 9.46M 1.57M 88K 1.04M 331K
Other Non-Cash Items
-7.59M -9.03M -9.47M 952K 1.43M 1.68M 1.64M -8.44M -6.69M -1.35M 6.13M 18.83M 8.16M 20.7M 38.32M 42.62M 58.59M 43.89M
Deferred Income Tax
n/a n/a n/a -10.54M -10.54M -10.54M -10.54M n/a n/a n/a n/a -11.06M 12K -11.05M n/a 11.06M -12K 11.05M
Change in Working Capital
-611K 1.34M -10.56M -22.52M -5.93M -11.55M 5.81M -230K -10.89M -8.24M -5.16M 11.9M 10.09M 10.02M 4.02M 1.8M 1.38M 601K
Operating Cash Flow
-105.7M -108.97M -130.87M -159.28M -158.48M -183.23M -166.52M -162.13M -151.46M -116.97M -98.77M -66.2M -53.23M -48.36M -38.65M -25.84M -16.7M -8M
Capital Expenditures
-64K -82K -241K -446K -494K -629K -514K -415K -464K -297K -275K -211K -317K -300K -262K -214K -11K n/a
Cash Acquisitions
n/a n/a n/a -46.34K -85.28K -120.29K -101.45K 1.17M 1.14M 1.18M 1.16M -64.26K n/a n/a 1.9M 1.9M 1.9M 1.9M
Purchase of Investments
-160.84M -277.68M -283.65M -237.08M -275.61M -188.89M -272.27M -448.33M -394.66M -387.4M -347.24M -302.05M -357.9M -301.18M -232.5M -72.96M n/a n/a
Sales Maturities Of Investments
230.76M 246.91M 268.38M 279.14M 327.37M 351.12M 373.73M 362.73M 334.37M 310.37M 272.58M -7.42M -88.79M -163.79M -216M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 46.34K 85.28K 120.29K 101.45K -1.17M -1.14M 17.1M 656.26K 234.38M 161.35M 143.08M 159.54M -72.96M n/a n/a
Investing Cash Flow
69.86M -30.86M -15.51M 41.62M 51.26M 161.6M 100.94M -86.03M -60.75M -77.32M -74.93M -77.18M -214.51M -232.77M -214.37M -71.28M 1.89M 1.9M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 450K 2.53M 4.43M 4.43M
Common Stock Repurchased
68K n/a n/a n/a n/a n/a n/a -10.36M -10.36M -10.36M -10.36M n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 140K 232K 232K 232K 2.56M 2.66M 2.55M 3.81M 1.59M 1.48M 161.18M 159.49M 158.97M 158.88M -700K -273K 1.08M
Financial Cash Flow
26.91M 25.93M 122.11M 122.72M 97.49M 100.87M 53.33M 42.39M 218.56M 216.33M 167.77M 337.71M 210.3M 266.77M 323.55M 166.05M 117.57M 61.92M
Net Cash Flow
-8.62M -113.82M -24.32M 5.16M -9.82M 79.2M -12.27M -205.69M 6.37M 21.98M -5.97M 194.28M -57.45M -14.3M 70.55M 68.93M 102.75M 55.82M
Free Cash Flow
-105.77M -109.05M -131.11M -159.72M -158.98M -183.85M -167.04M -162.55M -151.92M -117.26M -99.05M -66.42M -53.55M -48.66M -38.91M -26.05M -16.71M -8M